Noonberg Sarah B.
SEC CIK 1706301 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MGX | Metagenomi Therapeutics, Inc. | Chief Medical Off | 109.1K | — | $9,168 | 3 | 2024-04-01 | 2025-06-06 |
Most active insiders at MGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reid Laurence | Dir | $23.4K | — |
| 2 | Irish Jian | See Remarks, Dir | — | $12.7K |
| 3 | Wapnick Pamela | CFO | — | $11.3K |
| 4 | Thomas Brian C. | Dir | — | $6,779 |
| 5 | Wein Matthew | See Remarks | — | $2,263 |
Noonberg Sarah B. made no open-market trades at MGX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-09 | 2025-06-06 | MGX | Metagenomi Therapeutics, Inc. | Noonberg Sarah B. | Chief Medical Off | S - Sale | $1.75 | -5,239 | 109.1K | -5% | -$9,168 | |
| D | 2025-04-03 | 2025-04-01 | MGX | Metagenomi Therapeutics, Inc. | Noonberg Sarah B. | Chief Medical Off | A - Grant | $0.00 | +14.0K | 114.4K | +14% | $0 |
| D | 2024-04-03 | 2024-04-01 | MGX | Metagenomi Therapeutics, Inc. | Noonberg Sarah B. | Chief Medical Off | A - Grant | $0.00 | +57.8K | 100.4K | +136% | $0 |
Purchase Sale Sale after option exercise All abbreviations